1 year return (CAGR)
-41.18%
ADMA Biologics Inc Exchange (NASDAQ, USD)
ADMA
9.38
+0.40 (+4.34%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
35.98%
5 year return (CAGR)
51.78%
10 year return (CAGR)
5.06%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
2.13B
Price/Sales
4.16
Ent value
2.27B
Price/Book
5.22
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
12.60
PEG
-
Forward P/E
9.67
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 9.23 |
| Daily high | 9.54 |
| Daily low | 9.10 |
| Daily Volume | 2.86M |
| All-time high | 24.51 |
| 1y analyst estimate | 17.00 |
| Beta | 0.77 |
| EPS (TTM) | 0.73 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ADMA | S&P500 | |
| Current price drop from All-time high | -61.73% | -0.84% |
| Highest price drop | -91.27% | -56.47% |
| Date of highest drop | 11 Oct 2021 | 9 Mar 2009 |
| Avg drop from high | -53.77% | -10.68% |
| Avg time to new high | 70 days | 12 days |
| Max time to new high | 2418 days | 1805 days |
News
